Health & Biotech
Prescient Therapeutics hopes to accelerate bid for US FDA study approval for targeted therapy PTX-100
ASX Health Stocks: Healius gets takeover offer from company less than half its size
ScoPo’s Powerplays: ASX health stocks drop as Neuren surges 60% on US FDA approval
ASX Health Stocks: Neurotech says NTI164 works well in 11 autistic children after 52 weeks of treatment
Incannex to open psychedelic clinic’s business with leading Australian experts
ASX Health Stocks: High fives as Telix gets expanded FDA approval, Prescient’s PTX-100 returns good results
Incannex’s interim data predicts a statistically significant benefit for psilocybin therapy over placebo when treating anxiety, FDA IND application now in sight
Wellnex Life joins forces with Chemist Warehouse to enter SAS-B medicinal cannabis market
ASX Health Stocks: Patrys’ drug exhibits cancer lethality, US Patent Office says yes to Alterity
Could immunotherapy replace chemo? Here’s one stock that could rise 5x according to broker
ASX Health Stocks: Neuren surges 20pc on ‘historic’ FDA approval, HITIQ snaps up Monash Uni as customer
ASX Health Stocks: Volpara jumps 10pc as US FDA makes new ruling on ‘dense breasts’ language
Weed Week: BOD advances Aqua Phase acquisition with stability testing
Prescient’s PTX-100 granted FDA’s Orphan Drug Designation for all T-cell lymphomas
EZZ signs agreement with University of Auckland to conduct product research
Louie the beagle is beating the odds thanks to PharmAust’s canine cancer trial
Q&A: Nanoveu’s new chairman Dr David Pevcic says the market opportunity for antifouling solar panel coatings is in the billions
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
